152 related articles for article (PubMed ID: 24678053)
21. Light- and pH-responsive release of doxorubicin from a mesoporous silica-based nanocarrier.
Knežević NŽ; Trewyn BG; Lin VS
Chemistry; 2011 Mar; 17(12):3338-42. PubMed ID: 21337435
[No Abstract] [Full Text] [Related]
22. Core-Cone Structured Monodispersed Mesoporous Silica Nanoparticles with Ultra-large Cavity for Protein Delivery.
Xu C; Yu M; Noonan O; Zhang J; Song H; Zhang H; Lei C; Niu Y; Huang X; Yang Y; Yu C
Small; 2015 Nov; 11(44):5949-55. PubMed ID: 26426420
[TBL] [Abstract][Full Text] [Related]
23. Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves.
Meng H; Xue M; Xia T; Zhao YL; Tamanoi F; Stoddart JF; Zink JI; Nel AE
J Am Chem Soc; 2010 Sep; 132(36):12690-7. PubMed ID: 20718462
[TBL] [Abstract][Full Text] [Related]
24. Redox-Triggered Gatekeeper-Enveloped Starlike Hollow Silica Nanoparticles for Intelligent Delivery Systems.
Zhao N; Lin X; Zhang Q; Ji Z; Xu FJ
Small; 2015 Dec; 11(48):6467-79. PubMed ID: 26528765
[TBL] [Abstract][Full Text] [Related]
25. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
26. Activation of snap-top capped mesoporous silica nanocontainers using two near-infrared photons.
Guardado-Alvarez TM; Sudha Devi L; Russell MM; Schwartz BJ; Zink JI
J Am Chem Soc; 2013 Sep; 135(38):14000-3. PubMed ID: 24015927
[TBL] [Abstract][Full Text] [Related]
27. Stepwise-acid-active multifunctional mesoporous silica nanoparticles for tumor-specific nucleus-targeted drug delivery.
Li ZY; Liu Y; Hu JJ; Xu Q; Liu LH; Jia HZ; Chen WH; Lei Q; Rong L; Zhang XZ
ACS Appl Mater Interfaces; 2014 Aug; 6(16):14568-75. PubMed ID: 25103086
[TBL] [Abstract][Full Text] [Related]
28. Recent Advances in Application of Azobenzenes Grafted on Mesoporous Silica Nanoparticles in Controlled Drug Delivery Systems Using Light as External Stimulus.
Ramírez-Rave S; Bernad-Bernad MJ; Gracia-Mora J; Yatsimirsky AK
Mini Rev Med Chem; 2020; 20(11):1001-1016. PubMed ID: 31483228
[TBL] [Abstract][Full Text] [Related]
29. Stimulated release of size-selected cargos in succession from mesoporous silica nanoparticles.
Wang C; Li Z; Cao D; Zhao YL; Gaines JW; Bozdemir OA; Ambrogio MW; Frasconi M; Botros YY; Zink JI; Stoddart JF
Angew Chem Int Ed Engl; 2012 May; 51(22):5460-5. PubMed ID: 22505218
[No Abstract] [Full Text] [Related]
30. Controlled delivery using oligonucleotide-capped mesoporous silica nanoparticles.
Climent E; Martínez-Máñez R; Sancenón F; Marcos MD; Soto J; Maquieira A; Amorós P
Angew Chem Int Ed Engl; 2010 Sep; 49(40):7281-3. PubMed ID: 20737526
[No Abstract] [Full Text] [Related]
31. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
32. A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery.
Xiao D; Jia HZ; Zhang J; Liu CW; Zhuo RX; Zhang XZ
Small; 2014 Feb; 10(3):591-8. PubMed ID: 24106109
[TBL] [Abstract][Full Text] [Related]
33. Silica composite nanoparticles containing fluorescent solid core and mesoporous shell with different thickness as drug carrier.
Ran Z; Sun Y; Chang B; Ren Q; Yang W
J Colloid Interface Sci; 2013 Nov; 410():94-101. PubMed ID: 24011559
[TBL] [Abstract][Full Text] [Related]
34. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
35. Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles.
Pan L; Liu J; He Q; Wang L; Shi J
Biomaterials; 2013 Apr; 34(11):2719-30. PubMed ID: 23337327
[TBL] [Abstract][Full Text] [Related]
36. Intracellular delivery of core-shell fluorescent silica nanoparticles.
Fuller JE; Zugates GT; Ferreira LS; Ow HS; Nguyen NN; Wiesner UB; Langer RS
Biomaterials; 2008 Apr; 29(10):1526-32. PubMed ID: 18096220
[TBL] [Abstract][Full Text] [Related]
37. Aptamer-based nanoparticles for cancer targeting.
Sá LT; Simmons S; Missailidis S; da Silva MI; Santos-Oliveira R
J Drug Target; 2013 May; 21(5):427-34. PubMed ID: 23350808
[TBL] [Abstract][Full Text] [Related]
38. Pillar[6]arene-valved mesoporous silica nanovehicles for multiresponsive controlled release.
Huang X; Du X
ACS Appl Mater Interfaces; 2014 Nov; 6(22):20430-6. PubMed ID: 25336021
[TBL] [Abstract][Full Text] [Related]
39. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
40. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug.
Knežević NŽ; Lin VS
Nanoscale; 2013 Feb; 5(4):1544-51. PubMed ID: 23322330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
